Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection.
暂无分享,去创建一个
Steven J Brown | N. Uldbjerg | B. Bibby | J. Andrews | R. Gearry | I. Lawrance | G. Radford-Smith | L. A. Christensen | P. Gibson | S. Connor | C. Hvas | J. Kjeldsen | S. Bell | W. Connell | M. Sparrow | M. Julsgaard | J. Fallingborg | O. Rosella | A. Walsh | S. Wildt | L. Svenningsen | Kathrine Ellard | A. Grosen | L. Christensen | J. Andrews
[1] A. Bitton,et al. The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy. , 2016, Gastroenterology.
[2] M. Dubinsky,et al. The Effect of Maternal Peripartum Anti-TNFα Use on Infant Immune Response , 2016, Digestive Diseases and Sciences.
[3] F. Tse,et al. The Toronto Consensus Statements for the Management of IBD in Pregnancy. , 2015 .
[4] A. Bitton,et al. Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial , 2015, The Lancet.
[5] H. Boyd,et al. Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes , 2015, PloS one.
[6] C. J. van der Woude,et al. Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety , 2015, Gut.
[7] C. J. van der Woude,et al. The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. , 2015, Journal of Crohn's & colitis.
[8] José Villar,et al. International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project , 2014, The Lancet.
[9] M. Nørgaard,et al. Self-reported adherence to medical treatment, breastfeeding behaviour, and disease activity during the postpartum period in women with Crohn’s disease , 2014, Scandinavian journal of gastroenterology.
[10] Christopher F. Martin,et al. 1 Achievement of Developmental Milestones Among Offspring of Women With Inflammatory Bowel Disease: The PIANO Registry , 2014 .
[11] Christopher F. Martin,et al. 960 Exposure to Anti-TNFα Therapy in the Third Trimester of Pregnancy Is Not Associated With Increased Adverse Outcomes: Results From the PIANO Registry , 2014 .
[12] P. Munkholm,et al. Disease Course and Surgery Rates in Inflammatory Bowel Disease: A Population-Based, 7-Year Follow-Up Study in the Era of Immunomodulating Therapy , 2014, The American Journal of Gastroenterology.
[13] M. Lukáš,et al. Impact of Anti–Tumor Necrosis Factor Alpha Antibodies Administered to Pregnant Women With Inflammatory Bowel Disease on Long-term Outcome of Exposed Children , 2014, Inflammatory bowel diseases.
[14] L. A. Christensen,et al. Infliximab concentrations in the milk of nursing mothers with inflammatory bowel disease. , 2014, Journal of Crohn's & colitis.
[15] C. O'Morain,et al. Initial Disease Course and Treatment in an Inflammatory Bowel Disease Inception Cohort in Europe: The ECCO-EpiCom Cohort , 2014, Inflammatory bowel diseases.
[16] H. D. de Melker,et al. Varicella zoster virus infection occurs at a relatively young age in The Netherlands. , 2013, Vaccine.
[17] O. Nielsen,et al. Safety of TNF-α inhibitors during IBD pregnancy: a systematic review , 2013, BMC Medicine.
[18] N. Pedersen,et al. East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort , 2013, Gut.
[19] M. Dubinsky,et al. Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[20] J. Mate,et al. Safety of Thiopurines and Anti-TNF-α Drugs During Pregnancy in Patients With Inflammatory Bowel Disease , 2013, The American Journal of Gastroenterology.
[21] Ann-Beth Moller,et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications , 2012, The Lancet.
[22] Christopher F. Martin,et al. 865 PIANO: A 1000 Patient Prospective Registry of Pregnancy Outcomes in Women With IBD Exposed to Immunomodulators and Biologic Therapy , 2012 .
[23] R. Eliakim,et al. Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease. , 2011, Journal of Crohn's & colitis.
[24] E. Kuipers,et al. High intra‐uterine exposure to infliximab following maternal anti‐TNF treatment during pregnancy , 2011, Alimentary pharmacology & therapeutics.
[25] S. Travis,et al. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Pregnancy and Pediatrics , 2011, The American Journal of Gastroenterology.
[26] S. Shariq,et al. Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease. , 2010, Journal of Crohn's & colitis.
[27] S. Ben-Horin,et al. Adalimumab level in breast milk of a nursing mother. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[28] B. Vohr,et al. Maternal age, multiple birth, and extremely low birth weight infants. , 2009, The Journal of pediatrics.
[29] S. Kane,et al. Placental Transport of Immunoglobulins: A Clinical Review for Gastroenterologists Who Prescribe Therapeutic Monoclonal Antibodies to Women During Conception and Pregnancy , 2009, The American Journal of Gastroenterology.
[30] D. Corley,et al. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. , 2007, Gastroenterology.
[31] S. Kane,et al. The Role of Breastfeeding in Postpartum Disease Activity in Women with Inflammatory Bowel Disease , 2005, The American Journal of Gastroenterology.
[32] K. Nicolaides,et al. Evolution of Maternofetal Transport of Immunoglobulins During Human Pregnancy , 1996, American journal of reproductive immunology.
[33] C. Bodian,et al. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. , 2003, Gastroenterology.